0,36 $
1,69 %gestern
Nasdaq, 29. Februar, 22:13 Uhr
ISIN
IL0011552663
Symbol
GMDA
Berichte
Sektor
Industrie

Gamida Cell Ltd. Aktie News

Neutral
GlobeNewsWire
7 Tage alt
Expanded access program (EAP) data for omidubicel are consistent with Phase 3 trial results on rates of hematopoietic recovery and infections following stem cell transplant with Omisirge ® (omidubicel-onlv)
Neutral
GlobeNewsWire
etwa ein Monat alt
BOSTON, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced it is actively pursuing strategic alternatives in order to maximize value for all stakeholders, focusing on an asset sale, merger or other strategic transaction. However, there can be no assurance that the company's strategic alterna...
Neutral
GlobeNewsWire
etwa ein Monat alt
BOSTON, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced it will present new data on its FDA approved allogeneic stem cell therapy Omisirge® (omidubicel-onlv) and allogeneic cryopreserved natural killer (NK) cell therapy candidate GDA-201 at the 2024 Tandem Meetings, Transplantation & Cell...
Neutral
GlobeNewsWire
3 Monate alt
BOSTON, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, is hosting a virtual fireside chat with thought leader Gary Schiller, MD, FACP, Professor of Medicine and Director of the Hematological Malignancy & Stem Cell Transplant Program at the David Geffen School of Medicine at University of California – Lo...
Neutral
GlobeNewsWire
3 Monate alt
BOSTON, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that its management team will present corporate highlights at the upcoming Piper Sandler 35th Annual Healthcare Conference in New York, NY.
Neutral
Seeking Alpha
4 Monate alt
Gamida Cell Ltd. (NASDAQ:GMDA ) Q3 2023 Earnings Conference Call November 14, 2023 8:30 AM ET Company Participants Mike Kuczkowski - Corporate Communications Abbey Jenkins - President & Chief Executive Officer Michele Korfin - Chief Operating Officer & Chief Commercial Officer Ronit Simantov - Chief Medical Officer & Chief Scientific Officer Terry Coelho - Chief Financial Officer Conference Cal...
Neutral
GlobeNewsWire
4 Monate alt
Company continues to advance launch, reports initial revenue from Omisirge ® (omidubicel-onlv)
Neutral
GlobeNewsWire
4 Monate alt
Data further characterize the mechanism for Gamida Cell's proprietary nicotinamide (NAM) technology's expansion and enhancement of cells Data further characterize the mechanism for Gamida Cell's proprietary nicotinamide (NAM) technology's expansion and enhancement of cells

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen